Karolinska Institutet
Browse

Stem cell transplantation : home care, graft-versus-host disease and costs

Download (687.63 kB)
thesis
posted on 2024-09-02, 16:41 authored by Britt-Marie Svahn

Allogeneic stem-cell transplantation (ASCT) is used to treat malignant and non-malignant diseases of the immunohematopoietic system. Results in terms of survival rate and less complications are continually improving due to better knowledge, supportive care, immunosuppression, new drugs against infections and HLA-typing techniques. In transplant centres worldwide patients undergoing ASCT are treated in protective environments such as laminar airflow rooms, plastic bubbles, or reversed isolation. However, the isolation may lead to undesired psychosocial side-effects for the patient.

The main aim of this thesis was therefore to investigate whether it was safe and feasible to treat patients undergoing ASCT during the pancytopenic phase at home instead of at the hospital. Moreover, as the ASCT and post-transplant therapies are considered to be expensive, costs of ASCT and the treatment of severe GVHD grades III-IV were evaluated.

Paper I introduces a new approach showing it to be safe to treat patients undergoing ASCT at home as much as possible during the pancytopenic phase. In paper II, home-care was offered and evaluated in a larger group of patients. The study showed that the home-care regimen resulted in significantly reduced needs of total parenteral nutrition (TPN) (p=0.01) and analgesics (p=0.05); fewer patients with acute GVHD grades II-IV were identified (p<0.01); the time to discharge was shortened (p=0.01); there was less transplant-related mortality (TRM) (p<0.01); and there was a significantly better survival (p<0.03), compared with hospital-care. Because a less acute GVHD could predispose less chronic GVHD and increase the risk for relapse, we conducted a long-term follow-up study of the patients regarding this (paper III). However, no significant differences regarding chronic GVHD and relapse rate could be found in the home-care group, compared to the hospital-care group. In paper II, home-care was showed to be less costly compared to hospital care.

In paper IV, a more thorough cost analysis was performed, were the initial and the five consecutive post ASCT yearly costs were identified. It was showed that re-transplantation (p=0.004), prophylactic use of granulocyte colony-stimulating factors post ASCT (p=0.008), acute leukemia (p=0.008) and major complications, such as GVHD. bacteremia, hemorrhagic cystitis, and veno-occlusive disease of the liver, were associated with increased costs. In contrast, reduced intensity conditioning (p=0.01) and home-care (p<0.05) reduced the costs. In paper V, survival rate and costs regarding treatment of infections and severe acute GVHD (grades III-IV) between 1975 and 2004 were analysed. Since year 1999, the survival rate in patients with GVHD grades III-IV has improved significantly (9% vs. 21%, p=0.02); however, this improvement was found to be related to high costs.

To conclude, home-care may be offered during the pancytopenic phase to patients undergoing ASCT. Home-care may reduce the risk for acute GVHD, improve survival, and reduce the costs for ASCT. Major complications are costly. This thesis forms the basis for future strategies to further improve the patient care and to limit major transplant-related complications and costs.

List of scientific papers

I. Svahn BM, Bjurman B, Myrback KE, Aschan J, Ringden O (2000). Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant. 26(10): 1057-60.
https://doi.org/10.1038/sj.bmt.1702672

II. Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P, Aschan J, Barkholt L, Ringden O (2002). Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood. 100(13): 4317-24.
https://doi.org/10.1182/blood-2002-03-0801

III. Svahn BM, Ringden O, Remberger M (2005). Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 36(6): 511-6.
https://doi.org/10.1038/sj.bmt.1705096

IV. Svahn BM, Alvin O, Ringden O, Gardulf A, Remberger M (2006). Costs of allogeneic hematopoietic stem-cell transplantation. [Submitted]

V. Svahn BM, Alvin O, Ringden O, Remberger M (2006). Treatment, costs and survival in patients with grades III-IV acute graft-versus-host disease after allorgenic SCT during three decades. [Submitted]

History

Defence date

2006-02-10

Department

  • Department of Laboratory Medicine

Publication year

2006

Thesis type

  • Doctoral thesis

ISBN-10

91-7140-611-5

Number of supporting papers

5

Language

  • eng

Original publication date

2006-01-20

Author name in thesis

Svahn, Britt-Marie

Original department name

Department of Laboratory Medicine

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC